HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Keisuke Hirano Selected Research

Thrombosis (Thrombus)

10/2022Revascularization for controlling hypertension and improving cardiorenal failure in Leriche syndrome.
1/2021Efficacy of the novel technique HIRANODOME in preventing distal embolization during endovascular treatment of femoropopliteal lesions.
1/2018Efficacy and safety of a coagulated thrombus injection for peripheral artery perforation: The coagulated thrombus hemostasis method.
5/2017New endovascular technique for thrombus in the non-stenting zone-the Grab a Clot and Hold ON "(GACHON) technique": Case report.
4/2016Risk Factors and Clinical Impacts of Peri-Stent Contrast Staining After Second-Generation Drug-Eluting Stent Implantation.
3/2016Comparison of Long-Term Clinical Outcomes of Lesions Exhibiting Focal and Segmental Peri-Stent Contrast Staining.
2/2016Impact of ultra-long second-generation drug-eluting stent implantation.
11/2015Simultaneous occlusion of left anterior descending and left circumflex arteries by very late stent thrombosis: vascular response to drug-eluting stents assessed by intravascular ultrasound.
10/2014Vascular elastography: a novel method to characterize occluded lower limb arteries prior to endovascular therapy.
2/2012Natural history of side branches jailed by drug-eluting stents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Keisuke Hirano Research Topics

Disease

34Chronic Limb-Threatening Ischemia
10/2021 - 07/2010
10Thrombosis (Thrombus)
10/2022 - 02/2012
10Diabetes Mellitus
03/2021 - 10/2011
7Myocardial Infarction
01/2022 - 11/2002
7Ischemia
01/2021 - 04/2013
7Wounds and Injuries (Trauma)
01/2019 - 02/2015
5Renal Insufficiency (Renal Failure)
10/2022 - 01/2012
5Peripheral Arterial Disease
01/2022 - 01/2014
5Hemorrhage
01/2020 - 04/2016
5Cardiovascular Diseases (Cardiovascular Disease)
12/2016 - 08/2009
4Stroke (Strokes)
01/2022 - 01/2012
4Coronary Artery Disease (Coronary Atherosclerosis)
12/2016 - 06/2014
3No-Reflow Phenomenon
12/2021 - 01/2017
3Pathologic Constriction (Stenosis)
02/2020 - 01/2011
2Atrial Fibrillation
01/2021 - 11/2016
2AIDS-Related Complex (ARC)
10/2018 - 06/2018
2Infections
01/2018 - 03/2017
2Embolism (Embolus)
01/2018 - 05/2017
2Anemia
11/2017 - 11/2016
2Hematoma
04/2016 - 06/2014
2Death (Near-Death Experience)
02/2016 - 02/2012
2Heart Failure
09/2015 - 02/2013
2Chronic Kidney Failure (Chronic Renal Failure)
04/2013 - 02/2013
1Leriche Syndrome
10/2022
1Ecchymosis
01/2020
1Malnutrition (Nutritional Deficiencies)
01/2019
1Wound Infection (Wound Infections)
01/2019
1Neointima
10/2018
1Hypertension (High Blood Pressure)
11/2017
1Ulcer
11/2016
1Gastrointestinal Hemorrhage (Hematochezia)
04/2016
1Rupture
04/2016
1False Aneurysm (Pseudoaneurysm)
04/2016
1Atherosclerosis
03/2016
1Hyperemia
01/2016
1Penetrating Wounds (Penetrating Wound)
12/2015
1Cardiogenic Shock
11/2015
1Chronic Obstructive Pulmonary Disease (COPD)
01/2015
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
12/2014
1Left Ventricular Dysfunction
06/2014
1Intermittent Claudication
06/2014
1Arteriosclerosis Obliterans
09/2013
1Gangrene
02/2013

Drug/Important Bio-Agent (IBA)

8Cilostazol (Pletal)FDA LinkGeneric
11/2017 - 01/2011
8omega-Chloroacetophenone (Mace)IBA
09/2017 - 08/2009
3nitinolIBA
05/2017 - 09/2013
2Pharmaceutical PreparationsIBA
12/2021 - 01/2017
2Sirolimus (Rapamycin)FDA Link
04/2016 - 11/2015
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
09/2015 - 10/2013
2AlbuminsIBA
08/2015 - 04/2013
2C-Reactive ProteinIBA
04/2013 - 02/2013
1Phenobarbital (Luminal)FDA Link
10/2022
1Biomarkers (Surrogate Marker)IBA
10/2021
1N 30IBA
01/2019
1Indigo Carmine (Indigo Blue)IBA
01/2019
1LipidsIBA
10/2018
1CalciumIBA
06/2018
1ThrombinFDA Link
01/2018
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
11/2017
12'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA
11/2016
1PapaverineIBA
01/2016
1Capsules (Microcapsules)IBA
12/2015
1Indicators and Reagents (Reagents)IBA
12/2015
1Insulin (Novolin)FDA Link
06/2014
1Carvedilol (Coreg)FDA LinkGeneric
01/2014
1Bisoprolol (Concor)FDA LinkGeneric
01/2014
1CreatinineIBA
06/2013
1Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
01/2012

Therapy/Procedure

29Therapeutics
01/2022 - 02/2012
21Stents
01/2022 - 01/2011
17Renal Dialysis (Hemodialysis)
03/2021 - 07/2010
13Surgical Amputation (Amputations)
01/2021 - 01/2012
9Drug-Eluting Stents
01/2018 - 11/2015
5Limb Salvage
01/2019 - 03/2012
3Catheters
01/2020 - 04/2013
3Endovascular Procedures
05/2017 - 06/2014
2Punctures
01/2020 - 04/2016
2Percutaneous Coronary Intervention
12/2016 - 11/2002
1Transcatheter Aortic Valve Replacement
01/2020
1Activities of Daily Living (ADL)
08/2018
1Endovascular Aneurysm Repair
05/2017
1Vascular Surgical Procedures
03/2017